Unique ID issued by UMIN | UMIN000030212 |
---|---|
Receipt number | R000034495 |
Scientific Title | Single-center prospective cohort study of carotid-sparing intensity-modulated radiotherapy in early glottis cancer |
Date of disclosure of the study information | 2017/12/04 |
Last modified on | 2019/06/04 12:13:08 |
Single-center prospective cohort study of carotid-sparing intensity-modulated radiotherapy in early glottis cancer
Carotid-sparing intensity-modulated radiotherapy in early glottis cancer
Single-center prospective cohort study of carotid-sparing intensity-modulated radiotherapy in early glottis cancer
Carotid-sparing intensity-modulated radiotherapy in early glottis cancer
Japan |
Early glottis cancer
Oto-rhino-laryngology | Radiology |
Malignancy
NO
To clarify validity for carotid artery sclerosis by carotid-sparing intensity-modulated radiotherapy in early glottis cancer
To clarify safety for intensity-modulated radiotherapy in early glottis cancer by local control rate
Safety,Efficacy
Carotid intima-media thickness after radiotherapy 1,2 years later
Local control rate after radiotherapy 1,2 years later
Interventional
Parallel
Non-randomized
Open -no one is blinded
Active
2
Treatment
Other |
(Interventions)
Patients who receive carotid-sparing (max dose<35Gy) intensity-modulated radiotherapy in early glottis cancer
(Control)
Patients with head and neck cancer who receive radiotherapy (more than 50Gy) without carotid-saprinig
20 | years-old | <= |
Not applicable |
Male and Female
(Interventions)
Patients with glottis cancer who meet all of the following criteria;
1.Clinical T1 or T2 (UICC ver.7) glottis cancer diagnosed by laryngeal endoscope and CT or MRI
2.Pathologically confirmed squamous cell cancer
3.Clinical N0 and M0 diagnosed by neck CT and chest Xp (chest CT)
4.Age over 20
5.Performance status (ECOG) 0-2
6.No prior surgery or radiotherapy against neck
7.Written informed consent
(Control)
Patients with head and neck cancer who meet all of the following criteria;
1.Age over 20
2.Pathologically confirmed head and neck cancer
3.Will receive radiotherapy more than 50Gy
4.Performance status (ECOG) 0-2
5.Written informed consent
(Interventions/control)
1.Patients have psychiatric disorders that may comprise the patient's ability to receive radiotherapy
2.Patients who is considered ineligible for enrolling the study by a principal investigator or sub-investigator
60
1st name | Sasai |
Middle name | |
Last name | Keisuke |
Juntendo University
Department of Radiation Oncology
113-8431
Tokyo
+81338133111
ykosugi@juntendo.ac.jp
1st name | Kosugi |
Middle name | |
Last name | Yasuo |
Juntendo University
Department of Radiation Oncology
113-8431
Tokyo
+81338133111
ykosugi@juntendo.ac.jp
Juntendo University, Graduate School of Medicine, Department of Radiation Oncology
Juntendo University
Self funding
Japan
Juntendo Clinical Research and Trial Center
2-1-1 hongo,Bunkyo,Tokyo
03-3813-3111
kenkyu58585@juntendo.ac.jp
NO
2017 | Year | 12 | Month | 04 | Day |
Unpublished
Open public recruiting
2017 | Year | 10 | Month | 26 | Day |
2017 | Year | 11 | Month | 24 | Day |
2017 | Year | 12 | Month | 01 | Day |
2021 | Year | 12 | Month | 31 | Day |
2017 | Year | 12 | Month | 01 | Day |
2019 | Year | 06 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034495
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |